Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 409

Results For "ED"

11235 News Found

World Health Day: Late diagnosis, rising lifestyle diseases put young India at risk
Healthcare | April 07, 2026

World Health Day: Late diagnosis, rising lifestyle diseases put young India at risk

Sharp increase in diabetes, hypertension and fatty liver in 30–50 age group


Aurobindo Pharma’s CuraTeQ achieves Phase 3 success for Omalizumab biosimilar
Biopharma | April 07, 2026

Aurobindo Pharma’s CuraTeQ achieves Phase 3 success for Omalizumab biosimilar

The drug meets all primary endpoints across 608 patients in Europe and India, strengthening the company's biosimilars pipeline


Lupin secures global Great Place To Work certification for 2026-27
News | April 07, 2026

Lupin secures global Great Place To Work certification for 2026-27

Recognition across subsidiaries and geographies highlights pharma major’s focus on inclusive culture, employee experience, and global workforce development


Thyrocare’s Bharat Aarogyam score flags silent health risks in 9 out of 10 Indians
Healthcare | April 07, 2026

Thyrocare’s Bharat Aarogyam score flags silent health risks in 9 out of 10 Indians

Analysis of over 93 lakh preventive health checkups reveals disease risks emerging as early as the 20s


Sir Ganga Ram Hospital launches dialysis center in Gurgaon to expand renal care access
Hospitals | April 06, 2026

Sir Ganga Ram Hospital launches dialysis center in Gurgaon to expand renal care access

New facility in Sector 51 offers advanced, affordable, and patient-centric dialysis services for NCR patients


Samsung Biologics lands first US manufacturing facility with GSK acquisition
News | April 06, 2026

Samsung Biologics lands first US manufacturing facility with GSK acquisition

Samsung Biologics will continue supplying products previously manufactured at the site to GSK


Enveric Biosciences bags key US patent for mental health drug
Biotech | April 06, 2026

Enveric Biosciences bags key US patent for mental health drug

EB-003 is Enveric’s lead neuroplastogen, a 5-HT2A / 5-HT1B dual-acting compound designed to promote neuroplastic changes


Experts advocate holistic Semaglutide use as therapy goes off patent in India
Healthcare | April 06, 2026

Experts advocate holistic Semaglutide use as therapy goes off patent in India

They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market


Syngene appoints Maninder Kapoor Puri as Chief Human Resources Officer
People | April 06, 2026

Syngene appoints Maninder Kapoor Puri as Chief Human Resources Officer

Veteran HR leader comes with over two decades of experience to spearhead talent strategy, leadership development, and culture transformation


Biocon renames Irish step-down subsidiary as Biocon Biologics Ireland
Biotech | April 06, 2026

Biocon renames Irish step-down subsidiary as Biocon Biologics Ireland

Move aligns global biologics identity under the Biocon Biologics brand